Exploring the anti-inflammatory activity of sulforaphane.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing mechanistic pathways and published literature with no new empirical clinical data.
PubMed 37650498 · doi:10.1111/imcb.12686
What was done
This narrative review synthesized published evidence regarding the biological mechanisms, anti-inflammatory actions, and potential steroid-sparing applications of sulforaphane, a brassica-derived phytochemical.
What was found
The abstract reports no numerical data. Mechanistically, sulforaphane induces phase II detoxification enzymes via NRF2 signaling, negatively regulates NF-κB activation and downstream cytokine release, inhibits inflammasome activation, and directly modulates macrophage migration inhibitory factor activity.
Why it matters
Understanding the anti-inflammatory targets of sulforaphane may guide the development of adjunctive or alternative therapies that mitigate the adverse side effects associated with long-term glucocorticoid use.
Limits
As a narrative review, it provides no systematic search strategy, meta-analytic data, or novel clinical trial findings. The abstract reports no quantitative effect sizes, clinical dosing parameters, or human efficacy and safety outcomes.
Cited by
- supports Sulforaphane strongly activates the Nrf2 stress response pathway that upregulates detoxification genes.